CureDuchenneannounced today a new $7 million (€5M) collaboration with the biotechnology company Prosensa (NASDAQ: RNA) to help get experimental medicines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE